GlaxoSmithKline eliminates commercial ties with outside doctors following bribes

GSK will increase its in-house team of doctors by 10-20 percent this year

So you’re a pharmaceutical company, and you’ve just been accused of bribing doctors in a foreign country. What’s your next step? If you’re GlaxoSmithKline (GSK), the answer is eliminating much of the need for outside marketing altogether, as the company seeks to expand its team of in-house physicians by 10 to 20 percent over the next year.

GSK announced on April 17 that the company will be severing commercial ties with outside doctors. Instead, the company says, it will be expanding its in-house team already made up of 1,500 physicians.

Assistant Editor

author image

Zach Warren

Zach Warren is Assistant Editor of InsideCounsel magazine, where he oversees online content submissions and administers InsideCounsel's enewsletters. Zach specializes in new media and multimedia...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.